Raymond James Financial
FBIO icon

Raymond James Financial’s Fortress Biotech FBIO Stock Holding History

Raymond James Financial’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26
Closed -$48 – 5552
2025
Q2 		$48 Buy
+26
New +$45 ﹤0.01% 6887

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return

Raymond James Financial's FBIO Position: Q3 2025 in Review

Raymond James Financial sold out of Fortress Biotech (FBIO) in Q3 2025, closing a stake of 26 shares — an estimated $48 sold.

Raymond James Financial first reported a position in FBIO in Q2 2025 and held it in 1 quarter. The position peaked at $48 in Q2 2025. 56 funds tracked by Wall St. Rank hold FBIO as of Q3 2025.

  • Raymond James Financial reported no remaining Fortress Biotech position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 26 Fortress Biotech shares in Q3 2025, an estimated $48.
  • Raymond James Financial first reported a position in Fortress Biotech in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Fortress Biotech position peaked at $48 in Q2 2025.
  • 56 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.